News
SentinelOne (S) Q3 Earnings and Revenues Surpass Estimates
SentinelOne (S) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to break-even earnings per share a year ago. These figures
The Cooper Companies (COO) Q4 Earnings and Revenues Surpass Estimates
The Cooper Companies (COO) came out with quarterly earnings of $1.15 per share, beating the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $1.04 per share a year ago
Ulta Beauty (ULTA) Q3 Earnings and Revenues Beat Estimates
Ulta Beauty (ULTA) came out with quarterly earnings of $5.14 per share, beating the Zacks Consensus Estimate of $4.56 per share. This compares to earnings of $5.14 per share a year ago. These
Hewlett Packard Enterprise (HPE) Q4 Earnings Top Estimates
Hewlett Packard Enterprise (HPE) came out with quarterly earnings of $0.62 per share, beating the Zacks Consensus Estimate of $0.59 per share. This compares to earnings of $0.58 per share a year
DocuSign (DOCU) Q3 Earnings and Revenues Beat Estimates
DocuSign (DOCU) came out with quarterly earnings of $1.01 per share, beating the Zacks Consensus Estimate of $0.92 per share. This compares to earnings of $0.9 per share a year ago. These figures
Tap Into 2026 AI Infrastructure Gains With This High-Growth ETF
With 2026 just around the corner, there is no shortage of analyst forecasts predicting that AI will deliver tangible productivity and earnings gains in the year ahead, especially for the 493
Top Analyst Reports for HSBC, Abbott & Shell
Thursday, December 4, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including HSBC
AI Bubble? Non-Tech Stocks Worth a Look
Fears of an impending AI ‘bubble’ have mightily skewed sentiment among the beloved AI stocks over recent weeks, causing them to face adverse price action.
The bullish moves from these stocks is
Strong Quarter, Weak Reaction: Why GitLab Shares Dropped
Shares of GitLab Inc. (NASDAQ: GTLB) are down nearly 13.5% the day after the company delivered its fiscal year 2026 third-quarter earnings report.
The results were solid. In fact, revenue
Is the Options Market Predicting a Spike in F&G Annuities & Life Stock?
Investors in F&G Annuities & Life, Inc. FG need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 19, 2025 $20.00 Put had some of the highest
Are Options Traders Betting on a Big Move in exp World Stock?
Investors in exp World Holdings, Inc. EXPI need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 19, 2025 $05.00 Call had some of the highest
Is the Options Market Predicting a Spike in Equinor Stock?
Investors in Equinor ASA EQNR need to pay close attention to the stock based on moves in the options market lately. That is because the Dec. 19, 2025 $15 Call had some of the highest implied
Implied Volatility Surging for Eton Pharmaceuticals Stock Options
Investors in Eton Pharmaceuticals, Inc. ETON need to pay close attention to the stock based on moves in the options market lately. That is because the Dec. 19, 2025 $25 Call had some of the highest
3 Signs Tesla Is Starting December on the Front Foot
Shares of Tesla Inc. (NASDAQ: TSLA) closed just under $430 on Tuesday, up approximately 12% from their recent low near $385. For a stock that has spent the past three months stuck in a tight range
IonQ's 12% Pullback in a Month: Simply a Correction or Time to Sell?
IonQ’s IONQ stock stumbled over the past 30 days, sliding 12.2% even as the S&P 500 edged up 1.1%. However, many market watchers see this pullback as a healthy correction after the outsized rally
Buy Airline Stocks or the JETS ETF Amid Record Holiday Travel?
Airlines joined in on the rally that many retail stocks have been seeing amid what is expected to be a record holiday shopping season. It turns out that air travel is also seeing peaks with the
The Nuclear Revival Is Real: SMR Stocks Flash Buy Signals After DOE Push
The intersection of artificial intelligence (AI) and U.S. energy policy has officially ignited the Nuclear Renaissance. For years, investors have awaited a definitive signal that the nation is
Boeing's Bullish Breakout: Is This Rally Cleared for Takeoff?
Shares of The Boeing Company (NYSE: BA) ignited in early December, surging over 10% in a single session and capturing investor attention.
The dramatic rally was sparked by a newly confident
Brown-Forman's Q2 Earnings Miss Estimates, Gross Margin Expands Y/Y
Brown-Forman Corporation BF.B has reported mixed second-quarter fiscal 2026 results, wherein the top line beat the Zacks Consensus Estimate, while the bottom line missed the same. Both sales and
Should Investors Buy RYAAY Post a Bullish Fiscal 2026 Traffic Outlook?
European carrier, Ryanair Holdings RYAAY, has unveiled its raised traffic outlook for fiscal 2026, concurrent with its second-quarter fiscal 2026 earnings release on Nov. 3, 2025. As we know, higher
Wolfspeed Just Got a $698 Million Lifeline—Here’s Why That Changes Everything
On Dec. 1, 2025, Wolfspeed (NYSE: WOLF) received a piece of mail that fundamentally altered its financial trajectory: the Internal Revenue Service (IRS) delivered a cash refund totaling $698.6
PVH Corp Q3 Earnings Surpass Estimates, Revenues Increase Y/Y
PVH Corporation PVH posted third-quarter fiscal 2025 results, wherein both revenues and earnings topped the Zacks Consensus Estimate. However, the bottom line fell year over year, while the top line
Stocks to Watch as the AI-Driven Robotics Productivity Push Accelerates
U.S. Inflation is In Line with Historical Readings, Despite Tariff Fears
In the wake of U.S. President Donald Trump’s ‘Liberation Day’ reciprocal tariff rollout in April, stocks plummeted and many
Pharvaris Stock Gains on HAE Drug Meeting Late-Stage Study Goals
Shares of Pharvaris PHVS rose nearly 22% on Wednesday after the company announced positive results from the phase III RAPIDe-3 study evaluating its lead pipeline drug deucrictibant in the hereditary
